Glaxosmithkline Share Price | |
---|---|
Price | 1,653.00 |
Bid | 1,654.00 |
Ask | 1,654.50 |
Change | 12.50 (0.76%) |
Volume | 3,990,429 |
Open | 1,638.50 |
High | 1,655.50 |
Low | 1,634.00 |
Prev. Close | 1,640.50 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 4.09b |
Market Capitalisation | £67.54b |
Market Size | 1,500 |
52 Week High | 1,719.80 |
52 Week High Date | 07-Mar-2024 |
52 Week Low | 1,302.60 |
52 Week Low Date | 11-Jul-2023 |
# Trades | 6,138 |
---|---|
Vol. Sold | 2,304,622 |
Sold Value | £38.02m |
Vol. Bought | 951,814 |
Bought Value | £15.65m |
PE Ratio | 13.59375 |
Earnings | 121.60 |
Dividend | 55.50 |
Yield | 3.358% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
26-Apr-24 | 18:52:30 | 1,641.154 | 29,250 | Unknown* | 1,654.00 | 1,654.50 | 480.04k | O Ordinary Was reported as OTC |
26-Apr-24 | 14:54:06 | 1,645.00 | 0 | Unknown* | 1,654.00 | 1,654.50 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
26-Apr-24 | 18:09:23 | 1,652.173 | 8,291 | Unknown* | 1,654.00 | 1,654.50 | 136.98k | O Ordinary Was reported as OTC |
26-Apr-24 | 18:08:58 | 1,643.828 | 14,287 | Unknown* | 1,654.00 | 1,654.50 | 234.85k | O Ordinary Was reported as OTC |
26-Apr-24 | 18:07:50 | 1,646.54385 | 943 | Unknown* | 1,654.00 | 1,654.50 | 15.53k | O Ordinary Was reported as OTC |
26-Apr-24 | 18:07:40 | 1,639.655 | 9,271 | Unknown* | 1,654.00 | 1,654.50 | 152.01k | O Ordinary Was reported as OTC |
26-Apr-24 | 18:07:11 | 1,646.817 | 58,518 | Unknown* | 1,654.00 | 1,654.50 | 963.68k | O Ordinary Was reported as OTC |
26-Apr-24 | 18:00:02 | 1,653.00 | 2,915 | Unknown* | 1,654.00 | 1,654.50 | 48.18k | O Ordinary Was reported as OTC |
26-Apr-24 | 18:00:01 | 1,653.00 | 30 | Unknown* | 1,654.00 | 1,654.50 | 495.90 | O Ordinary Was reported as OTC |
26-Apr-24 | 17:59:31 | 1,653.00 | 296 | Unknown* | 1,654.00 | 1,654.50 | 4,893 | O Ordinary Was reported as OTC |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
19-Apr-24 | 16-Apr-24 | Buy Dividends | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 39.79 | USD | 2,906,213 | 3,370,704 |
19-Apr-24 | 16-Apr-24 | Buy Dividends | Emma Walmsley held the position of CEO at the time of this trade.Emma Walmsley | 1,611.28 | GBX | 1,840,922 | 2,190,842 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Anne Beal held the position of Independent Non-Executive Director at the time of this trade.Anne Beal | 40.96 | USD | 9 | 3,375 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Harry (Hal) C. Dietz held the position of Independent Non-Executive Director at the time of this trade.Harry (Hal) C. Dietz | 40.96 | USD | 9 | 3,118 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 40.96 | USD | 13 | 464,491 |
At GSK, we unite science, technology and talent to get ahead of disease together